98 related articles for article (PubMed ID: 6785371)
1. Immunochemical characterization of antibodies to factor VIII in hemophilic and nonhemophilic patients.
Allain JP; Gaillandre A; Lee H
J Lab Clin Med; 1981 Jun; 97(6):791-800. PubMed ID: 6785371
[TBL] [Abstract][Full Text] [Related]
2. The immunological characterization of human antibodies to factor VIII isolated by immuno-affinity chromatography.
Kavanagh ML; Wood CN; Davidson JF
Thromb Haemost; 1981 Feb; 45(1):60-4. PubMed ID: 6787728
[TBL] [Abstract][Full Text] [Related]
3. IgG subclasses of anti-FVIII antibodies during immune tolerance induction in patients with hemophilia A.
van Helden PM; van den Berg HM; Gouw SC; Kaijen PH; Zuurveld MG; Mauser-Bunschoten EP; Aalberse RC; Vidarsson G; Voorberg J
Br J Haematol; 2008 Aug; 142(4):644-52. PubMed ID: 18510679
[TBL] [Abstract][Full Text] [Related]
4. Immunochemical characterization of factor VIII inhibitors.
Hoyer LW; Gawryl MS; de la Fuente B
Prog Clin Biol Res; 1984; 150():73-85. PubMed ID: 6431443
[TBL] [Abstract][Full Text] [Related]
5. A potential new procedure for removing anti-factor VIII antibodies from hemophilic plasma.
Regnault V; Rivat C; Vallet JP; Francois-Gerard C; Brochier G; Allain JP
Thromb Res; 1987 Jan; 45(1):51-7. PubMed ID: 3105113
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneity of factor VIII antibodies: further immunochemical and biologic studies.
Hultin MB; London FS; Shapiro SS; Yount WJ
Blood; 1977 May; 49(5):807-17. PubMed ID: 403984
[TBL] [Abstract][Full Text] [Related]
7. [Acquired inhibitors (autoantibodies) to coagulation factors in non-hemophilic patients].
Okamura T; Tsuda H
Rinsho Ketsueki; 1993 May; 34(5):583-7. PubMed ID: 7686235
[TBL] [Abstract][Full Text] [Related]
8. IgG subclass antibodies to human cytomegalovirus (CMV) in normal human plasma samples and immune globulins and their neutralizing activities.
Gupta CK; Leszczynski J; Gupta RK; Siber GR
Biologicals; 1996 Jun; 24(2):117-24. PubMed ID: 8889058
[TBL] [Abstract][Full Text] [Related]
9. Characterization of human hybridoma clones isolated from hemophilia patients with specificity for different domains of coagulating factor VIII.
Gharagozlou S; Ghods R; Bahrami ZS; Roohi A; Jeddi-Tehrani M; Conti-Fine BM; Sharifian RA; Rabbani H; Shokri F
Hum Antibodies; 2003; 12(3):67-76. PubMed ID: 14646035
[TBL] [Abstract][Full Text] [Related]
10. IgGs containing light chains of the λ- and κ- type and of all subclasses (IgG1-IgG4) from the sera of patients with systemic lupus erythematosus hydrolyze myelin basic protein.
Bezuglova AM; Konenkova LP; Buneva VN; Nevinsky GA
Int Immunol; 2012 Dec; 24(12):759-70. PubMed ID: 22899672
[TBL] [Abstract][Full Text] [Related]
11. The effect of naturally occurring antibodies to factor VIII on an immunoradiometric assay for factor VIII coagulant antigen. Observation on a cross-reacting material-positive (CRM+) hemophiliac with a factor VIII inhibit.
Brown JE; Carton CL; Hougie C
J Lab Clin Med; 1981 Jan; 97(1):65-71. PubMed ID: 6778942
[TBL] [Abstract][Full Text] [Related]
12. A longitudinal evaluation of anti-FVIII antibodies demonstrated IgG4 subclass is mainly correlated with high-titre inhibitor in haemophilia A patients.
Montalvão SA; Tucunduva AC; Siqueira LH; Sambo AL; Medina SS; Ozelo MC
Haemophilia; 2015 Sep; 21(5):686-92. PubMed ID: 25708525
[TBL] [Abstract][Full Text] [Related]
13. [Identification of IgG subclass and FVIII binding epitope of an acquired FVIII inhibitor in a bullous pemphigoid patient].
Zuo WL; Zhang GS; Qing ZJ; Xu YX; Qin LX; Xu M
Zhonghua Xue Ye Xue Za Zhi; 2006 Sep; 27(9):593-7. PubMed ID: 17278424
[TBL] [Abstract][Full Text] [Related]
14. Association of anti-idiotypic antibodies with immune tolerance induction for the treatment of hemophilia A with inhibitors.
Sakurai Y; Shima M; Tanaka I; Fukuda K; Yoshida K; Yoshioka A
Haematologica; 2004 Jun; 89(6):696-703. PubMed ID: 15194537
[TBL] [Abstract][Full Text] [Related]
15. Blockade of CD40/CD40 ligand interactions prevents induction of factor VIII inhibitors in hemophilic mice but does not induce lasting immune tolerance.
Reipert BM; Sasgary M; Ahmad RU; Auer W; Turecek PL; Schwarz HP
Thromb Haemost; 2001 Dec; 86(6):1345-52. PubMed ID: 11776297
[TBL] [Abstract][Full Text] [Related]
16. Restricted epitope specificity of anti-FVIII antibodies that appeared during a recent outbreak of inhibitors.
Gilles JG; Peerlinck K; Arnout J; Vermylen J; Saint-Remy JM
Thromb Haemost; 1997 May; 77(5):938-43. PubMed ID: 9184406
[TBL] [Abstract][Full Text] [Related]
17. The properties of immune complexes formed by human antibodies to factor VIII.
Lazarchick J; Hoyer LW
J Clin Invest; 1977 Nov; 60(5):1070-9. PubMed ID: 908750
[TBL] [Abstract][Full Text] [Related]
18. Long-term persistence of anti-factor VIII antibody-secreting cells in hemophilic mice after treatment with human factor VIII.
Hausl C; Maier E; Schwarz HP; Ahmad RU; Turecek PL; Dorner F; Reipert BM
Thromb Haemost; 2002 May; 87(5):840-5. PubMed ID: 12038787
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibodies to human procoagulant factor VIII.
Rotblat F; Goodall AH; O'Brien DP; Rawlings E; Middleton S; Tuddenham EG
J Lab Clin Med; 1983 May; 101(5):736-46. PubMed ID: 6403638
[TBL] [Abstract][Full Text] [Related]
20. Characterization of antibodies induced by human factor VIII in a murine knockout model of hemophilia A.
Reipert BM; Ahmad RU; Turecek PL; Schwarz HP
Thromb Haemost; 2000 Nov; 84(5):826-32. PubMed ID: 11127864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
